CRIS Current Research Information System

COCCO, LUCIO ILDEBRANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.479
EU - Europa 10.098
AS - Asia 4.340
AF - Africa 694
SA - Sud America 28
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 19
Totale 27.683
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.454
GB - Regno Unito 2.697
IT - Italia 1.945
CN - Cina 1.673
SE - Svezia 1.496
DE - Germania 1.472
VN - Vietnam 938
SG - Singapore 871
IN - India 521
UA - Ucraina 499
IE - Irlanda 394
FR - Francia 389
RU - Federazione Russa 351
TG - Togo 280
ZA - Sudafrica 214
EE - Estonia 212
CH - Svizzera 111
BG - Bulgaria 105
HR - Croazia 100
NG - Nigeria 99
JP - Giappone 98
BE - Belgio 74
JO - Giordania 73
CI - Costa d'Avorio 64
FI - Finlandia 63
AT - Austria 62
KR - Corea 51
GR - Grecia 34
SC - Seychelles 34
CA - Canada 25
NL - Olanda 21
RO - Romania 18
IR - Iran 17
AU - Australia 16
TR - Turchia 16
EU - Europa 15
HK - Hong Kong 15
BR - Brasile 13
PL - Polonia 12
UZ - Uzbekistan 11
LB - Libano 10
PK - Pakistan 10
NZ - Nuova Zelanda 9
ES - Italia 8
CL - Cile 7
DK - Danimarca 6
IL - Israele 6
HU - Ungheria 5
MY - Malesia 5
PT - Portogallo 5
BD - Bangladesh 4
EC - Ecuador 4
LU - Lussemburgo 4
MD - Moldavia 4
CZ - Repubblica Ceca 3
PH - Filippine 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
EG - Egitto 2
ID - Indonesia 2
LK - Sri Lanka 2
MN - Mongolia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SS - ???statistics.table.value.countryCode.SS??? 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
DZ - Algeria 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
Totale 27.683
Salva come PNG Salva come JPEG
Città #
Southend 2.447
Fairfield 1.674
Chandler 1.237
Ashburn 1.087
Houston 798
Woodbridge 786
Singapore 742
Wilmington 714
Ann Arbor 700
Seattle 653
Bologna 612
Princeton 588
Cambridge 586
Dong Ket 487
Dublin 393
Jacksonville 292
Lomé 280
Nanjing 262
Westminster 259
Padova 249
Berlin 180
Santa Clara 156
Beijing 141
Saint Petersburg 135
Jinan 127
San Diego 122
Shenyang 112
Sofia 105
Milan 104
Abeokuta 98
New York 92
Bern 88
Nanchang 88
Changsha 82
Florence 82
Redwood City 77
Boardman 74
Hebei 73
Amman 72
Medford 70
Brussels 69
Abidjan 64
Tokyo 63
Mülheim 62
Turin 62
Helsinki 60
Bremen 53
Falls Church 46
Norwalk 45
Vienna 45
Frankfurt am Main 44
Redmond 44
Dearborn 42
Guangzhou 41
Des Moines 40
Haikou 38
Tianjin 38
Jiaxing 37
Shanghai 37
Hangzhou 33
Zhengzhou 33
Mahé 32
Rome 31
Mountain View 30
Ningbo 29
Olalla 26
Los Angeles 25
Tappahannock 25
Verona 25
London 24
Kunming 23
Parma 22
Taiyuan 22
Taizhou 22
Washington 22
Lanzhou 21
Sejong 21
Bühl 17
Chicago 17
Modena 17
Locri 16
San Francisco 16
San Venanzo 15
Forlì 14
Fuzhou 14
Cesena 13
Toronto 13
Buffalo 12
Paris 12
Ravenna 12
Valsamoggia 12
Wuhan 12
Amsterdam 10
Hefei 10
Reggio Emilia 10
São Paulo 10
Wenzhou 10
Ferrara 8
Lausanne 8
Moscow 8
Totale 18.606
Salva come PNG Salva come JPEG
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 239
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes 212
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response 200
A role for PKCepsilon during C2C12 myogenic differentiation 190
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 189
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. 176
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 174
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 173
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. 169
ALIVE CEROPLASTICS 4D Representations 167
Inositide-Dependent Nuclear Signalling in Health and Disease 167
Multiple roles of phosphoinositide-specific phospholipase C isozymes. 164
Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2 160
Nuclear inositide signaling and cell cycle 158
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes 158
Endoscopic endonasal anatomy of the ophthalmic artery in the optic canal 155
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide 154
BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation 154
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS 150
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 150
Communication between median and musculocutaneous nerve at the level of cubital fossa - A case report 150
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. 149
Inositide signaling in the nucleus: From physiology to pathology. 149
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) 147
null 144
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS 144
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 144
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES 143
Endoscopic endonasal approach to primitive Meckel's cave tumors: a clinical series 143
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes 142
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 141
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy 141
Anatomical variations of the right renal and spermatic arteries: a case report 138
A role for PKR in hematologic malignancies 137
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 135
Revisiting nuclear phospholipase C signalling in MDS 135
Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna 135
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 135
Advances in Targeting Signal Transduction Pathways. 132
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 132
Nuclear Inositide Signaling via Phospholipase C 132
AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity 132
Nuclear inositides: facts and perspectives. 130
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts 130
Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress 128
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. 128
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C βI 127
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 127
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 127
Protein kinase C involvement in cell cycle modulation 126
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 125
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 125
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia 124
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study 124
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 122
Nuclear phospholipase C beta1 and cellular differentiation. 120
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 119
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients 119
Frequent Elevation of Akt Kinase Phosphorylation in Blood Marrow and Peripheral Blood Mononuclear Cells from High Risk myelodysplastic Syndrome Patients 118
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients 118
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 118
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 118
A role for PLCbeta1 in myotonic dystrophies type 1 and 2. 117
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study 117
Expression of signal transductions proteins during the differentiation of primary human erythroblasts 116
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells 116
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 116
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 116
Regulation of nuclear phospholipase C activity 115
Advances in Enzyme Regulation 115
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 115
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 115
Nuclear inositol lipid metabolism: more than just second messenger generation? 115
Advances in Enzyme Regulation 114
Advances in Enzyme Regulation 113
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients 113
Nuclear inositide specific phospholipase C signalling - interactions and activity 113
Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C 113
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 113
Mineral fiber-mediated activation of phosphoinositide-specific phospholipase c in human bronchoalveolar carcinoma-derived alveolar epithelial A549 cells. 112
PLC and PI3K/Akt/mTOR signalling in disease and cancer 112
Nuclear inositide signaling in myelodysplastic syndromes. 111
Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia 111
Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature 110
Near-peer teaching in human anatomy from a tutors’ perspective: An eighteen-year-old experience at the university of Bologna 110
Physiology and pathology of nuclear phospholipase C beta1 109
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis 109
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 109
Expression of phosphoinositide-specific phospholipase C isoenzymes in cultured astrocytes 108
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 108
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 108
Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia 107
Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy 107
Increased transcription of mitochondrial genes for Complex I in human platelets during ageing 107
Zafirlukast promotes insulin secretion by increasing calcium influx through L-type calcium channels 107
Diacylglycerol kinase (DGK) involvement in K562 erythroleukemia cell proliferation 107
PI-PLCβ1 gene copy number alterations in breast cancer 106
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 106
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 106
Modulation of nuclear PI-PLCbeta1 during cell differentiation 106
Totale 13.240
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.733 0 0 0 389 657 706 858 856 1.092 467 324 384
2020/20213.683 784 247 126 147 71 188 107 233 314 186 159 1.121
2021/20225.558 549 132 354 471 461 313 159 360 178 773 923 885
2022/20235.733 599 743 327 782 459 427 289 339 900 121 411 336
2023/20241.922 110 302 180 188 221 330 95 69 91 139 76 121
2024/20251.922 216 954 616 136 0 0 0 0 0 0 0 0
Totale 28.412